EPIC Program Annual Data Tables 2004-2005: Table VIII

Table VIII
Twenty Most Frequently Purchased Drugs*
Rank by Number
of Claims
DrugStrengthDrug
Type**
Number
of Claims
EPIC
Payments
Rank by
Payment
Top 20 Totals2,269,554$168,508,867
Percent of Top 20 Drugs to Total Paid Claims20.4%22.5%
1FUROSEMIDE40MGGen173,187$744,896174
2LIPITOR10MGSS170,901$16,637,4024
3PLAVIX75MGSS163,485$28,794,6961
4FOSAMAX70MGSS159,708$15,459,3487
5NORVASC5MGSS134,163$8,030,76512
6HYDROCHLOROTHIAZIDE25MGGen129,366$414,539306
7METOPROLOL TARTRATE50MGGen128,538$565,455232
8PROTONIX40MGSS112,131$15,990,2886
9FUROSEMIDE20MGGen110,779$423,137293
10LIPITOR20MGSS110,462$16,473,3575
11TOPROL XL50MGSS101,719$3,107,78043
12ATENOLOL50MGGen101,348$561,563234
13NORVASC10MGSS97,926$7,846,01414
14PREVACID30MGSS89,151$17,574,0943
15METFORMIN HCL500MGGen85,304$1,541,90998
16NEXIUM40MGSS85,113$17,767,7802
17AMBIEN10MGSS81,874$5,436,06922
18ACTONEL35MGSS79,042$7,029,02716
19ATENOLOL25MGGen78,495$479,272263
20XALATAN0.005%SS76,862$3,631,47635

* Table VIII lists the top 20 drugs ranked by number of adjudicated claims for the program year (October 1, 2004-September 30, 2005) as well as the percentage of the totals they represent for the year.

** Drug Type values are Gen='Generic' and SS='Sole Source'.